ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Australian Competition and Consumer Commission
The following articles have the tag Australian Competition and Consumer Commission
Cancer ‘healer’ facing court
A QUEENSLAND man who claims he can cure cancer with diet and exercise is now facing court over the credibility of his treatment regime. The Australian Competition and Consumer Commission (ACCC) alleges medical treatment claims by Darryl Peter Jones, principal of the Darryl Jones Health Resolution Centre on the Sunshine Coast, are misleading or deceptive under the Trade Practices Act. Before being shut down early last year, the Darryl Jones Health Resolution Centre's website advertised a cancer treatment program involving an exercise regime, the consumption of vitamin B17 and restriction of glucose in the diet. The ...
Generics transparency under scrutiny
THE Generic Medicines Industry Association (GMiA) wants rules governing the transparency of its dealings with pharmacy to be relaxed. It is seeking concessions from the Australian Competition and Consumer Commission (ACCC) on demands for greater transparency of relationships between pharmacists and generic drugs manufacturers under its new Code of Practice. The ACCC last month announced plans to grant a conditional three-year authorisation to the GMiA Code of Practice. However, it imposed the condition that association members – who supply more than 90% of generic medicines – will be required to disclose all educational events and promotional ...
Pharmacists face scrutiny over dealings with generics
PHARMACISTS will face the same level of scrutiny as doctors in their dealings with pharmaceutical companies, with generic manufacturers now required to report on hospitality, loyalty schemes, incentives and gifts offered to pharmacists. The Australian Competition and Consumer Commission (ACCC) announced plans to grant a conditional three-year authorisation to the Generic Medicines Industry Association (GMiA) Code of Practice. But it has imposed the condition that GMiA members – who supply more than 90% of generic medicines in Australia – will be required to disclose all non-cash incentives for pharmacists, as well as doctors. GMiA CEO Kate ...
It's official: Ads banned in practice software
THE Medicines Australia Code of Conduct was yesterday given the final stamp of approval from the Australian Competition and Consumer Commission (ACCC), spelling the official end of brand-name reminders and product advertisements in practice software. The green light for the code comes as the Medicines Australia Code of Conduct Committee released its annual report, showing pharmaceutical companies were hit with a total of $1.42 million in fines in 2008-09. This was down from the $1.83 million recorded in 2007-08. The new Code of Conduct will take effect from 1 January and will significantly tighten regulations around pharmaceutical ...